# US 2012/0251574 A1 · Endopeptidase and Neurotoxin Combination Treatment of Multiple Medical Conditions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251574 A1
- Document ID: US20120251574A1
- Status: Published application
- Kind: A1
- Application number: 13/425,229
- Filed: 2012-03-20
- Published: 2012-10-04
- Earliest claimed: 2011-03-28
- Assignees: Allergan, Inc.
- Inventors: Andrew M. Blumenfeld; Mitchell F. Brin
- Web page: https://patentgrep.com/patent/US20120251574A1

## CPC

- A61K 38/164: {from bacteria}
- A61K 38/4893: {Botulinum neurotoxin (3.4.24.69)}
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/06: Antimigraine agents
- A61P 25/14: for treating abnormal movements, e.g. chorea, dyskinesia
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present specification discloses Clostridial neurotoxins and TEMs, compositions comprising such Clostridial neurotoxins and TEMs, methods of treating a multiple medical disorder in an individual using such compositions, use of such Clostridial neurotoxins and TEMs in manufacturing a medicament for treating a multiple medical disorder, and uses of such Clostridial neurotoxins and TEMs in treating a multiple medical disorder.

## Claims

### Claim 1

A method of treating a multiple medical disorder in an individual, the method comprising the step of administering to the individual in need thereof a therapeutically effective amount of a composition including a Clostridial neurotoxin and a TEM comprising a targeting domain, a Clostridial toxin translocation domain and a Clostridial toxin enzymatic domain, wherein the targeting domain is a sensory neuron targeting domain, a sympathetic neuron targeting domain, or a parasympathetic neuron targeting domain, and wherein administration of the composition reduces a symptom of the multiple medical disorder, thereby treating the individual.

### Claim 2 (depends on 1)

The method of claim 1, wherein the TEM comprises a linear amino-to-carboxyl single polypeptide order of 1) the Clostridial toxin enzymatic domain, the Clostridial toxin translocation domain, the targeting domain, 2) the Clostridial toxin enzymatic domain, the targeting domain, the Clostridial toxin translocation domain, 3) the targeting domain, the Clostridial toxin translocation domain, and the Clostridial toxin enzymatic domain, 4) the targeting domain, the Clostridial toxin enzymatic domain, the Clostridial toxin translocation domain, 5) the Clostridial toxin translocation domain, the Clostridial toxin enzymatic domain and the targeting domain, or 6) the Clostridial toxin translocation domain, the targeting domain and the Clostridial toxin enzymatic domain.

### Claim 3 (depends on 1)

The method of claim 1, wherein the multiple medical disorder is a dystonia or a cerebral palsy.

### Claim 4 (depends on 3)

The method of claim 3, wherein the dystonia is a focal dystonia, a segmental dystonia, a multifocal dystonia, a generalized dystonia, or an acute dystonic reaction.

### Claim 5 (depends on 4)

The method of claim 4, wherein the focal dystonia is a cervical dystonia, a blepharospasm, a lingual dystonia, an oromandibular dystonia, a laryngeal dystonia, a limb dystonia, a truncal dystonia, an abdominal wall dystonia, and an anismus.

### Claim 6 (depends on 4)

The method of claim 4, wherein the segmental dystonia is an oculogyric crisis or a cranial dystonia.

### Claim 7 (depends on 3)

The method of claim 3, wherein the cerebral palsy is a spastic palsy, a dyskinetic palsy, a hypotonic palsy, or a mixed palsy.

### Claim 8

A method of treating a multiple medical disorder in an individual, the method comprising the step of administering to the individual in need thereof a therapeutically effective amount of a composition including a Clostridial neurotoxin and a TEM comprising a targeting domain, a Clostridial toxin translocation domain, a Clostridial toxin enzymatic domain, and an exogenous protease cleavage site, wherein the targeting domain is a sensory neuron targeting domain, a sympathetic neuron targeting domain, or a parasympathetic neuron targeting domain, and wherein administration of the composition reduces a symptom of the multiple medical disorder, thereby treating the individual.

### Claim 9 (depends on 8)

The method of claim 8, wherein the TEM comprises a linear amino-to-carboxyl single polypeptide order of 1) the Clostridial toxin enzymatic domain, the exogenous protease cleavage site, the Clostridial toxin translocation domain, the targeting domain, 2) the Clostridial toxin enzymatic domain, the exogenous protease cleavage site, the targeting domain, the Clostridial toxin translocation domain, 3) the targeting domain, the Clostridial toxin translocation domain, the exogenous protease cleavage site and the Clostridial toxin enzymatic domain, 4) the targeting domain, the Clostridial toxin enzymatic domain, the exogenous protease cleavage site, the Clostridial toxin translocation domain, 5) the Clostridial toxin translocation domain, the exogenous protease cleavage site, the Clostridial toxin enzymatic domain and the targeting domain, or 6) the Clostridial toxin translocation domain, the exogenous protease cleavage site, the targeting domain and the Clostridial toxin enzymatic domain.

### Claim 10 (depends on 8)

The method of claim 8, wherein the Clostridial toxin translocation domain is a BoNT/A translocation domain, a BoNT/B translocation domain, a BoNT/C1 translocation domain, a BoNT/D translocation domain, a BoNT/E translocation domain, a BoNT/F translocation domain, a BoNT/G translocation domain, a TeNT translocation domain, a BaNT translocation domain, or a BuNT translocation domain.

### Claim 11 (depends on 8)

The method of claim 8, wherein the Clostridial toxin enzymatic domain is a BoNT/A enzymatic domain, a BoNT/B enzymatic domain, a BoNT/C1 enzymatic domain, a BoNT/D enzymatic domain, a BoNT/E enzymatic domain, a BoNT/F enzymatic domain, a BoNT/G enzymatic domain, a TeNT enzymatic domain, a BaNT enzymatic domain, or a BuNT enzymatic domain.

### Claim 12 (depends on 8)

The method of claim 8, wherein the exogenous protease cleavage site is a plant papain cleavage site, an insect papain cleavage site, a crustacian papain cleavage site, an enterokinase cleavage site, a human rhinovirus 3C protease cleavage site, a human enterovirus 3C protease cleavage site, a tobacco etch virus protease cleavage site, a Tobacco Vein Mottling Virus cleavage site, a subtilisin cleavage site, a hydroxylamine cleavage site, or a Caspase 3 cleavage site.

### Claim 13 (depends on 8)

The method of claim 8, wherein the multiple medical disorder is a dystonia, a cerebral palsy, or a migraine.

### Claim 14 (depends on 13)

The method of claim 13, wherein the dystonia is a focal dystonia, a segmental dystonia, a multifocal dystonia, a generalized dystonia, or an acute dystonic reaction.

### Claim 15 (depends on 14)

The method of claim 14, wherein the focal dystonia is a cervical dystonia, a blepharospasm, a lingual dystonia, an oromandibular dystonia, a laryngeal dystonia, a limb dystonia, a truncal dystonia, an abdominal wall dystonia, and an anismus.

### Claim 16 (depends on 14)

The method of claim 14, wherein the segmental dystonia is an oculogyric crisis or a cranial dystonia.

### Claim 17 (depends on 13)

The method of claim 13, wherein the cerebral palsy is a spastic palsy, a dyskinetic palsy, a hypotonic palsy, or a mixed palsy.

### Claim 18 (depends on 13)

The method of claim 13, wherein the migraine is a migraine without aura, a migraine with aura, a menstrual migraine, a migraine equivalent, a complicated migraine, an abdominal migraine or a mixed tension migraine.
